Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety Is in the Air: Ultraviolet light to clean the air typically has to be positioned away from people. Devices using shorter UV wavelengths could change this.

Scientific American·2024
Same author

How organoids are advancing the understanding of chronic kidney disease.

Nature·2023
Same author

Disinfecting the air with far-ultraviolet light.

Nature·2022
Same author

Finding medical value in mescaline.

Nature·2022
Same author

Facing the challenge of eliminating hepatitis B.

Nature·2022
Same author

An Email Coaching Option Increases Participant Program Utilization and Coach Productivity.

American journal of health promotion : AJHP·2022
Same journal

Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancer.

Cancer discovery·2026
Same journal

DNA, Peptide Vaccines Advance Against GBM.

Cancer discovery·2026
Same journal

AKR1C1 Promotes ADC Resistance by Altering Uptake and Export.

Cancer discovery·2026
Same journal

Acquisition of Centromeric Features Supports Telomere Integrity.

Cancer discovery·2026
Same journal

Germline CDK12 variants in aggressive prostate cancer.

Cancer discovery·2026
Same journal

Type II JAK2 Inhibitor Gets Off to a Strong Start.

Cancer discovery·2026
See all related articles

Related Experiment Video

Updated: May 12, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Cancer centers prepare for sequestration cuts.

Eric Bender

    Cancer Discovery
    |April 13, 2013
    PubMed
    Summary
    This summary is machine-generated.

    Automatic U.S. federal budget cuts are impacting cancer centers, forcing them to prepare for reduced spending. These cost-saving measures must be implemented rapidly within the fiscal year.

    More Related Videos

    Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
    08:49

    Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

    Published on: January 13, 2023

    Enhancing Tumor Content through Tumor Macrodissection
    10:04

    Enhancing Tumor Content through Tumor Macrodissection

    Published on: February 12, 2022

    Related Experiment Videos

    Last Updated: May 12, 2026

    Stereotactic Radiosurgery for Gynecologic Cancer
    10:35

    Stereotactic Radiosurgery for Gynecologic Cancer

    Published on: April 17, 2012

    Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
    08:49

    Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

    Published on: January 13, 2023

    Enhancing Tumor Content through Tumor Macrodissection
    10:04

    Enhancing Tumor Content through Tumor Macrodissection

    Published on: February 12, 2022

    Area of Science:

    • Oncology
    • Public Health Policy
    • Healthcare Economics

    Background:

    • U.S. federal budget sequestration has been enacted, leading to automatic spending reductions.
    • Cancer centers face imminent financial challenges due to these mandated budget cuts.
    • The compressed timeframe for achieving cost savings presents a significant hurdle.

    Discussion:

    • The implications of reduced federal funding on cancer research and patient care are substantial.
    • Cancer centers must develop strategic financial plans to navigate budget shortfalls.
    • The timing of these cuts necessitates immediate and decisive action.

    Key Insights:

    • Federal budget cuts directly threaten the financial stability of cancer centers.
    • The need for rapid cost reduction in the latter half of the fiscal year intensifies the challenge.
    • Proactive financial planning is crucial for mitigating the impact of these cuts.

    Outlook:

    • Cancer centers may need to re-evaluate research priorities and operational expenditures.
    • Potential for decreased access to cutting-edge cancer treatments and clinical trials.
    • Advocacy for stable research funding is paramount for the future of oncology.